Tarsus Pharmaceuticals In... (TARS)
45.22
0.89 (2.01%)
At close: Jan 15, 2025, 1:52 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -4.38 | -5.81 | -33.45 | -31.33 | -85.97 | -66.86 |
| PS Ratio | 34.10 | 13.98 | 8.11 | n/a | n/a | n/a |
| PB Ratio | 3.02 | 1.87 | 2.77 | 5.06 | -66.86 | -65.13 |
| P/FCF Ratio | -4.84 | -7.29 | 146.26 | -38.9 | -104.34 | -74.11 |
| P/OCF Ratio | -5.06 | -7.36 | 123.39 | -39.74 | -109.31 | -74.55 |
| OCF/S Ratio | -6.73 | -1.9 | 0.07 | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.16 | 0.10 | 0.01 | 0.01 | -0.03 | n/a |
| Quick Ratio | 6.85 | 14.30 | 15.33 | 31.68 | 70.83 | 13.31 |
| Current Ratio | 6.93 | 14.61 | 15.33 | 31.68 | 70.85 | 13.31 |
| Asset Turnover | 0.07 | 0.11 | 0.32 | n/a | n/a | n/a |
| Interest Coverage | -42.78 | -28.52 | n/a | -143.61 | -107.45 | n/a |
| Return on Equity (ROE) | -0.69 | -0.32 | -0.08 | -0.16 | 0.78 | 0.97 |
| Return on Assets (ROA) | -0.51 | -0.27 | -0.08 | -0.16 | -0.08 | -0.55 |
| Return on Capital (ROIC) | -0.63 | -0.3 | -0.07 | -0.16 | -0.07 | -0.61 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 90.87% | 96.30% | 96.36% | n/a | n/a | n/a |
| Net Profit Margin | -778.89% | -240.51% | -24.25% | n/a | n/a | n/a |
| Pretax Profit Margin | -778.89% | -240.53% | -24.15% | n/a | n/a | n/a |
| Operating Profit Margin | -820.53% | -242.92% | -21.32% | n/a | n/a | n/a |
| FCF Margin | -704.96% | -191.88% | 5.54% | n/a | n/a | n/a |
| EBITDA Margin | -754.69% | -228.95% | -23.09% | n/a | n/a | n/a |